Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates

Posted byZacks Equity Research Leave a comment on Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates

Editas (EDIT) delivered earnings and revenue surprises of 21.79% and 181.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Leave a comment

Your email address will not be published. Required fields are marked *